News


Please see the below for our press releases, upcoming events and to follow our news:

Press releases

Feb 2019       TopiVert Announces Publication of Data from its Positive Phase 2 Study with TOP1630 in Dry Eye Disease in Peer-reviewed Journal
Apr 2018       TopiVert to Present TOP1630 clinical Proof-of-Concept data in Dry Eye Syndrome at the ARVO 2018 Annual Meeting

Mar 2018      TopiVert Publication Highlights the Potential of Narrow Spectrum Kinase Inhibitors in Dry Eye Disease 

Jan 2018        TopiVert announces positive Phase 1 study results with its oral formulation of TOP1288 for the treatment of ulcerative colitis 

Nov 2017      TopiVert demonstrates proof of concept in Phase 1/2a study of TOP1630 in the treatment of dry eye syndrome

Jun 2017        TopiVert completes three clinical studies for its two lead NSKI programmes in ulcerative colitis and dry eye syndrome 

Feb 2017       TopiVert commences Phase I study with oral TOP1288 in the treatment of ulcerative colitis 

                       TopiVert commences proof of concept study for TOP1630 in the treatment of dry eye syndrome

Nov 2016      TopiVert receives IND approval for TOP1630 in the treatment of dry eye syndrome

Oct 2016       TopiVert doses first patients in TOP1288 Phase 2a POC study in ulcerative colitis

May 2016      TopiVert completes preclinical development with TOP1630 for dry eye disease 

                       TopiVert to present First-In-Human data from its Phase I clinical study with TOP1288 at DDW 2016 in San Diego 

Mar 2016      TopiVert reports successful Phase I study with TOP1288 for the treatment of ulcerative colitis

                       TopiVert to present First-In-Human data from its Phase I clinical study with TOP1288 at ECCO

May 2015      Topivert starts Phase I Clinical Trial with lead compound, TOP1288, in Ulcerative Colitis

Dec 2011       £8 million funding for new start-up TopiVert

upcoming Events

TopiVert will be attending a number of industry and medical conferences throughout 2018. 

 

Ophthalmology Innovation Summit (OIS) @ AAO | 25th October 2018 | Marriott Marquis, Chicago, IL, USA

To meet with Topivert please contact:

Anuj Madhok (Chief Business Officer)
anuj.madhok@topivert.com
+44 (0)776 688 4436

Follow our news

Please enter your email address in the news alerts entry box in the footer below if you would like to receive news updates from TopiVert.

You can also follow us on Twitter at @TopiVert or using #topivert and also our thread #NSKI